IBD 50 Shows Lots Of Stocks Poised To Break OutInvestor’s Business DailyLook at Alexion Pharmaceuticals (ALXN), whose drugs target cancer, autoimmune disorders and transplant rejection. The stock has shaped a tight, low-volume flat base. The buy point …
McCann does its part to boost organ donation – Malaysia Star
Malaysia StarMcCann does its part to boost organ donationMalaysia Star“Incidentally, one of our colleagues is an organ donor and we feel that it is timely for us to launch a campaign for the public to pledge their organs to help the those in need and…
Everolimus plus paclitaxel failed to improve pathological complete response rate – HemOncToday
HemOncTodayEverolimus plus paclitaxel failed to improve pathological complete response rateHemOncTodaySAN ANTONIO — Adding everolimus to 12 weeks of paclitaxel as neoadjuvant therapy did not improve the rate of pathological complete response in patie…
Hedge Fund's $621 Million Invested in Healthcare Stocks: CEPH, JNJ, PFE – Wall St. Cheat Sheet
Hedge Fund's $621 Million Invested in Healthcare Stocks: CEPH, JNJ, PFEWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant re…
HDFC Bank's blood donation drive evokes good response – GreaterKashmir.com
GreaterKashmir.comHDFC Bank's blood donation drive evokes good responseGreaterKashmir.comSrinagar, Dec 9: HDFC Bank's nationwide 'Blood Donation Drive' on Friday saw people turning up in droves to donate blood at 679 centres in 521 loca…
Researchers discover a mechanism of drug resistance – Brandeis University
Brandeis UniversityResearchers discover a mechanism of drug resistanceBrandeis UniversityPenicillium molds are best known for making penicillin, but also produce the not-so-famous mycophenolic acid, a billion-dollar drug used to ward off organ rejectio…
Breast Cancer Survival Up With Everolimus + Exemestane – Monthly Prescribing Reference
USA TodayBreast Cancer Survival Up With Everolimus + ExemestaneMonthly Prescribing Reference(HealthDay News) – Everolimus plus exemestane improves progression-free survival (PFS) for postmenopausal women with hormone-receptor (HR)-positive breast cance…
mTOR inhibitors gaining favor for breast cancer treatment – Emory Health Now (blog)
CBC.camTOR inhibitors gaining favor for breast cancer treatmentEmory Health Now (blog)Ruth O'Regan, MD, director of the Translational Breast Cancer Research Program at Winship Cancer Institute, has led clinical studies of everolimus in breast cance…
Local Organ Donor's Gift of Life to Be Honored in Rose Parade – Boise Weekly
Boise WeeklyLocal Organ Donor's Gift of Life to Be Honored in Rose ParadeBoise WeeklyToday, her family helped celebrate her double gift of organ donation. This morning, officials from the Idaho Transportation Department, Donate Life Northwest, and …
Research and Markets: Heart Transplantation Global Clinical Trials Review, H2 … – Business Wire (press release)
Research and Markets: Heart Transplantation Global Clinical Trials Review, H2 …Business Wire (press release)GlobalData's clinical trial report, Heart Transplantation Global Clinical Trials Review, H2, 2011" provides data on the Heart Transpl…